Overjet’s Clinical Intelligence Platform combines real-time dental AI analysis insight and existing practice management software data to support clinical and business teams.
“After months of use, we were impressed by Overjet’s ability to support and guide our clinical providers which ultimately helps them deliver consistent and high quality patient care,” said Patrick Assioun, DMD, CEO of New England Family Dentistry. “AI has already had a great impact in businesses and medicine, and dentistry is no different.”
Earlier in 2021, Overjet received FDA clearance for its dental assist product, the first dental AI company to receive such a clearance. The product uses AI to measure bone levels in radiographs for the diagnosis and treatment planning of periodontal disease.
Overjet also intends for its technology to soon support shared reimbursement standards between providers and payers.
